Biotech Essentials

Startups

Biotech Startups Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 30.06.2021.

#biotech
#IPO
#SPAC
#startups
#pharma
#ClimateCrisis
#AMD
#investments
#diabetes

Startups

@ScottKirsner shared
On Jun 28, 2021
RT @goldbergcarey: They called it a conspiracy theory. But Alina Chan tweeted life into the idea that the virus came from a lab. https://t.co/YSo0lFQUff
Open
They called it a conspiracy theory. But Alina Chan tweeted life into the idea that the virus came from a lab.

They called it a conspiracy theory. But Alina Chan tweeted life into the idea that the virus came from a lab.

The whistleblowing scientist who advanced the lab-leak theory plans to change her name and disappear, but only after a book deal.

@ForbesTech shared
On Jun 24, 2021
The future of psychedelic medicine might skip the trip https://t.co/ME6OlVjYqC by @WillYakowicz
Open
The Future Of Psychedelic Medicine Might Skip The Trip

The Future Of Psychedelic Medicine Might Skip The Trip

A hallucinogenic experience may draw people to LSD and psilocybin, but the mental health industry believes there's a $50 billion opportunity in turning these compounds into safe at-home ...

@big4bio shared
On Jun 24, 2021
RT @big4bioSD: Singular Genomics (@SingularGenomi1) ($OMIC) is just one of many to go public this year. The nationwide IPO boom is helping San Diego #startups take advantage of the stock market to become publicly traded. #IPO #SPAC #biotech #pharma Learn more here: https://t.co/TWDxIv1PuW
Open
More San Diego startups are taking advantage of a hot stock market to become publicly traded

More San Diego startups are taking advantage of a hot stock market to become publicly traded

The nationwide IPO boom is helping the region's life sciences and tech firms tap public markets, setting the stage for what could be a record number of IPOs this year

@nvca shared
On Jun 29, 2021
RT @BatteryVentures: As we move toward the post-pandemic recovery, the US startup ecosystem will play a critical role creating the jobs of the future. Here are 5 @NVCA policy recommendations Washington should consider to keep the US positioned as a global innovation leader https://t.co/Z6DvcInEFc
Open
5 policies Washington should enact to end the climate crisis and joblessness

5 policies Washington should enact to end the climate crisis and joblessness

The problems we seek to address may be unique to our time, but the source of our solutions remains the same: expanding entrepreneurial activity.

@FiercePharma shared
On Jun 28, 2021
We're looking for 2021's Fiercest Women in Life Sciences https://t.co/hfq15nGjZh
Open
We're looking for 2021's Fiercest Women in Life Sciences

We're looking for 2021's Fiercest Women in Life Sciences

Each year at Fierce, we spotlight women who are leading the way in biotech, pharma and medtech. Be sure to submit your nominations by 11:59 p.m. EDT Monday, Aug. 2, for consideration in ...

@IAmBiotech shared
On Jun 29, 2021
Biotechnology is on a mission. To cure diseases once thought incurable. And to make seemingly impossible breakthroughs possible. But breakthroughs don’t happen all by themselves. That’s where BIO comes in - BIO is where breakthroughs begin. Learn more: https://t.co/z5hTXPWWVp https://t.co/aiiOJ2ly33
Open
About BIO

About BIO

BIO is the world’s largest advocacy association representing member companies, state biotechnology groups, academic and research institutions, and related organizations across the United ...

@labcentral shared
On Jun 24, 2021
RT @genentech: #Biotech startups: We’re giving away one free year of lab space at @labcentral in Boston. Confirm your eligibility and apply for our Golden Ticket giveaway (certain conditions and restrictions apply): https://t.co/RPIg7yewBK https://t.co/oYJUq4i3IQ
Open
LabCentral Golden Ticket

LabCentral Golden Ticket

Breakthrough science. One moment, one day, one person at a time.

@big4bio shared
On Jun 28, 2021
.@Oxurion ($OXUR) is focusing its #investments on two of its lead clinical candidates, Pan-RGD integrin antagonist THR-687 and plasma kallikrein inhibitor THR-149 for treating macular edema. Both will be in Phase 2. #biotech #AMD #diabetes Read more here: https://t.co/KNht4HK7zF
Open
Oxurion stops investing in cancer spinout, reduces head count

Oxurion stops investing in cancer spinout, reduces head count

Oxurion is stopping investing in its oncology spinout and narrowing its focus to its two clinical assets. The restructuring will affect “a number” of people who work at Oxurion and put the ...